| European Case Law Identifier: | ECLI:EP:BA:1998:T051394.19980423 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 23 April 1998 | ||||||||
| Case number: | T 0513/94 | ||||||||
| Application number: | 80301357.2 | ||||||||
| IPC class: | C12N 5/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Monoclonal-antibody-producing hybrid cell line, antibody and method of preparing it, therapeutic composition containing it and its diagnostic and therapeutic uses | ||||||||
| Applicant name: | Ortho Pharmaceutical Corporation | ||||||||
| Opponent name: | Behringwerke Aktiengesellschaft Becton, Dickinson and Company Novartis AG Patent- und Markenabteilung Boehringer Mannheim GmbH Patentabteilung |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Sufficiency of disclosure (yes) Inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t940513eu1.html
Date retrieved: 17 May 2021